Rep-Biotech Joint Doctoral Project is an European Network created to train the new generation of excellent researchers in the Biology and Technology of Reproductive Health (both human and animal).
Rep-Biotech Joint Doctoral Project is a Marie-Skłodowska Curie Innovative Training Network funded by the European Commission under the Horizon 2020 Programme and is composed of 12 leading academic research groups and 3 companies from 9 different countries: Spain, France, Ireland, Italy, Belgium, Germany, USA, Japan and The Netherlands.
The Network started on November 1st 2015 and will end on October 31st 2019.
The main objective of the European Doctorate in Biology and Technology of the Reproductive Health (REP-BIOTECH) is to build a research, training and academic programme in the interdisciplinary domain of reproductive health and fertility. Basic knowledge of mechanisms involved in mammalian fertilization and embryo development provides useful strategies to improve food quality (by implementation of efficient and secure animal reproductive technologies), human health (by contributing to the control of reproductive diseases and epidemiologic factors) and human and animal fertility (by identifying target molecules for successful conception or contraception).
REP-BIOTECH is a PhD programme with the aim of training a new generation of creative, entrepreneurial and innovative Early-Stage Researchers (ESRs). ESRs must carry out independent research on a specific topic to be awarded a European Joint Degree from 5 European Universities (Beneficiaries).
The PhD project will be jointly supervised within a joint governance structure in which the beneficiaries as well as the partner organisations will be actively involved. The Doctorate programme will expose ESRs to different sectors and they will acquire a comprehensive set of transferable skills working in the specific research area relating to their doctoral thesis.
The consortium has a proven track record in their area and they have a history of fruitful scientific collaboration. Moreover, giving the diversity amongst the participating institutions, the ESRs will be able to face current and future challenges in order to convert knowledge and ideas into products and services for economic and social benefit. The strength of the partnership lies in being a multidisciplinary group (animal and human fertility, reproductive health and reproductive technologies) within the cooperation of 7 different European countries, the collaboration of Universities from Japan and United States and partners from the non academic sector.